Kura Oncology KURA Interest Expense
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by Kura Oncology in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kura Oncology's interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kura Oncology's interest expense?
- Kura Oncology (KURA) reported interest expense of $336K in Q1 2026.
- How has Kura Oncology's interest expense changed year-over-year?
- Kura Oncology's interest expense decreased by 12.0% year-over-year, from $382K to $336K.
- What is the long-term trend for Kura Oncology's interest expense?
- Over 3 years (2022 to 2025), Kura Oncology's interest expense has grown at a 87.6% compound annual growth rate (CAGR), from $229K to $1.51M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.